Table: begin end state 1 27 signal peptide 28 35 non-cytoplasmic 36 53 transmembrane 54 58 cytoplasmic 59 75 transmembrane 76 80 non-cytoplasmic 81 101 transmembrane 102 107 cytoplasmic 108 129 transmembrane 130 140 non-cytoplasmic 141 161 transmembrane 162 167 cytoplasmic 168 186 transmembrane 187 218 non-cytoplasmic 219 239 transmembrane 240 257 cytoplasmic 258 280 transmembrane 281 290 non-cytoplasmic 291 309 transmembrane 310 316 cytoplasmic 317 338 transmembrane 339 349 non-cytoplasmic 350 379 transmembrane 380 481 cytoplasmic
Input: >AO353_23030 FitnessBrowser__pseudo3_N2E3:AO353_23030 MKSKRLRADALAGLTTSFALLPECIAFALVAHLNPLMGLYGAFIICTLTALFGGRPGMIS GAAGSMAVVIVALVVQHGVQYLLATVLMGGLLMMAFGLLRLGKLVRMVPYPVMLGFVNGL AIVIALAQLEHFKSGGTWLSGTALYLMIGLVALTMAIVYVLPRLTRAVPPALVAILGVGL AVYLLGLPTRTLGDMAHIAGGLPGLALPQVPWNLETLRIVAPYAVLMALVGLLETLLTLN LTDEITESRGYPDRECVALGAANMVSGLFGGMGGCAMIGQTVINLSSSGRGRLSGVVAGV MILLFILFLSPQIERIPLAALVGVMFVVAQQTFAWASLRVLNKVPLNDVLVIIAVTIITV FTDLAIAVLCGIVIAALNFAWQQARELYADSYLEADGSKLYRLHGTLFFASTAPFLNQFD PANDPPQVTLDCRHLSFVDYSAVAALKTLRERYVKTGKQLRVYHLSERCKKMLKRAGVDH D
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server